Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer.
about
Direct metabolic interrogation of dihydrotestosterone biosynthesis from adrenal precursors in primary prostatectomy tissues.Androgen Signaling in Prostate Cancer.Overcoming Oncogenic Mediated Tumor Immunity in Prostate Cancer.Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer.Beyond the androgen receptor II: New approaches to understanding and treating metastatic prostate cancer; Report from the 2017 Coffey-Holden Prostate Cancer Academy Meeting.Steroidogenic Metabolism of Galeterone Reveals a Diversity of Biochemical Activities.Delineation of the androgen-regulated signaling pathways in prostate cancer facilitates the development of novel therapeutic approaches.Epigenetic Regulation in Prostate Cancer Progression.Measuring glucocorticoid receptor expression in vivo with PET.Mechanisms and Approaches for Overcoming Enzalutamide Resistance in Prostate Cancer.Clinical and Genomic Crosstalk between Glucocorticoid Receptor and Estrogen Receptor α In Endometrial Cancer.
P2860
Q38696620-8F7A022A-F073-43BB-A360-492BB32FDCF4Q39227656-F97A51F2-BB03-4C3C-993D-48BD3EA84F12Q39438805-9E3577F5-1278-45A4-BFC4-64B2B10F9482Q41349840-809C8525-9055-4F61-B46C-24D90CB3801AQ43578455-28C788FA-9B81-430C-A9CF-366A5471E8D5Q50925353-CCD686E4-5D02-4C26-BAA8-4E2B07BDA368Q53699332-15AD2B32-A06E-4E6D-8D45-589FF7FA55E5Q54974720-DB568EE4-8283-4B83-8E7C-1426D0D39375Q55248523-E246AD49-F328-4295-966D-B2D02315F3A8Q55331819-DFCAD4EB-F487-4E3D-BCFA-63BA757D8B9FQ55423955-8F8D24C5-B8C3-4643-A509-5307B0CD1734
P2860
Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aberrant corticosteroid metabo ...... ide resistant prostate cancer.
@en
Aberrant corticosteroid metabo ...... ide resistant prostate cancer.
@nl
type
label
Aberrant corticosteroid metabo ...... ide resistant prostate cancer.
@en
Aberrant corticosteroid metabo ...... ide resistant prostate cancer.
@nl
prefLabel
Aberrant corticosteroid metabo ...... ide resistant prostate cancer.
@en
Aberrant corticosteroid metabo ...... ide resistant prostate cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
Aberrant corticosteroid metabo ...... mide resistant prostate cancer
@en
P2093
Cristina Magi-Galluzzi
Eric A Klein
Jianneng Li
Jorge A Garcia
Kai-Hsiung Chang
Kevin Courtney
Mary-Ellen Taplin
Michael Berk
Mohammad Alyamani
P2860
P356
10.7554/ELIFE.20183
P407
P577
2017-02-13T00:00:00Z